Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | XFOR | ANL | ||
| Company | Cellular Biomedicine | X4 Pharmaceuticals Inc | Adlai Nortye Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.74 | 4.15 | 10.58 | ||
| High | 19.75 | 4.30 | 11.35 | ||
| Low | 19.73 | 4.08 | 8.54 | ||
| Latest | 19.75 | 4.13 | 9.49 | ||
| Change | unch | +0.05 | -1.11 | ||
| % Change | unch | +1.10% | -10.47% | ||
| Volume | 171,900 | 678,900 | 480,900 | ||
| 20-Day Average Volume | 197,580 | 1,049,885 | 153,370 | ||
| Previous Close | 19.75 | 4.09 | 10.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 4.04 | 10.49 | ||
| 20-Day Raw Stochastic | 99.77% | 45.19% | 27.46% | ||
| 20-Day Relative Strength | 67.50 | 50.98 | 42.98 | ||
| Weighted Alpha | +21.75 | +11.43 | +4.65 | ||
| Today's Opinion | 100% Buy | 80% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 64% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Sell | 40% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | +3.51% since 06/25/26 | -6.59% since 06/25/26 | ||
| Low | 19.68 on 02/12/21 | 3.98 on 06/26/26 | 8.54 on 07/02/26 | ||
| High | 19.75 on 02/18/21 | 4.70 on 07/01/26 | 12.00 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | +2.23% since 06/02/26 | -18.05% since 06/02/26 | ||
| Low | 17.60 on 01/28/21 | 3.66 on 06/08/26 | 8.54 on 07/02/26 | ||
| High | 19.75 on 02/18/21 | 4.70 on 07/01/26 | 12.00 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | -2.59% since 04/02/26 | +16.01% since 04/02/26 | ||
| Low | 17.60 on 01/28/21 | 3.56 on 05/19/26 | 7.20 on 04/15/26 | ||
| High | 19.75 on 02/18/21 | 4.70 on 07/01/26 | 17.25 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | +6.17% since 01/02/26 | +587.68% since 01/02/26 | ||
| Low | 16.98 on 11/06/20 | 2.83 on 02/18/26 | 1.32 on 01/06/26 | ||
| High | 19.75 on 02/18/21 | 4.83 on 03/10/26 | 17.25 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 389,542 | 379,600 | ||
| Shares Outstanding, K | 19,478 | 94,320 | 40,000 | ||
| Annual Sales | 340,000 | 35,110,000 | 5,000,000 | ||
| Annual Net Income | -49,980,000 | -79,200,000 | -35,530,000 | ||
| Last Quarter Sales | 30,000 | 2,710,000 | 0 | ||
| Last Quarter Net Income | -17,040,000 | -20,240,000 | -63,397,000 | ||
| 60-Month Beta | 1.17 | 0.35 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.16 on 05/06/26 | N/A on 09/29/23 | ||
| Earnings Date | 02/26/21 | 08/14/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||